Khan SR - Search Results

1

Benzoylphenylurea sulfur analogues with potent antitumor activity.

Hallur G, Jimeno A, Dalrymple S, Zhu T, Jung MK, Hidalgo M, Isaacs JT, Sukumar S, Hamel E, Khan SR. Hallur G, et al. Among authors: khan sr. J Med Chem. 2006 Apr 6;49(7):2357-60. doi: 10.1021/jm051261s. J Med Chem. 2006. PMID: 16570932

2

Development of two novel benzoylphenylurea sulfur analogues and evidence that the microtubule-associated protein tau is predictive of their activity in pancreatic cancer.

Jimeno A, Hallur G, Chan A, Zhang X, Cusatis G, Chan F, Shah P, Chen R, Hamel E, Garrett-Mayer E, Khan S, Hidalgo M. Jimeno A, et al. Mol Cancer Ther. 2007 May;6(5):1509-16. doi: 10.1158/1535-7163.MCT-06-0592. Epub 2007 May 4. Mol Cancer Ther. 2007. PMID: 17483439

3

Synthesis and antitumor evaluation of benzoylphenylurea analogs.

Gurulingappa H, Amador ML, Zhao M, Rudek MA, Hidalgo M, Khan SR. Gurulingappa H, et al. Among authors: khan sr. Bioorg Med Chem Lett. 2004 May 3;14(9):2213-6. doi: 10.1016/j.bmcl.2004.02.019. Bioorg Med Chem Lett. 2004. PMID: 15081011

4

Design, synthesis and biological evaluation of novel riccardiphenol analogs.

Kumar SK, Amador M, Hidalgo M, Bhat SV, Khan SR. Kumar SK, et al. Among authors: khan sr. Bioorg Med Chem. 2005 Apr 15;13(8):2873-80. doi: 10.1016/j.bmc.2005.02.010. Bioorg Med Chem. 2005. PMID: 15781397

5

Modulating paclitaxel bioavailability for targeting prostate cancer.

Kumar SK, Williams SA, Isaacs JT, Denmeade SR, Khan SR. Kumar SK, et al. Among authors: khan sr. Bioorg Med Chem. 2007 Jul 15;15(14):4973-84. doi: 10.1016/j.bmc.2007.04.029. Epub 2007 Apr 25. Bioorg Med Chem. 2007. PMID: 17502149

6

Novel microtubule-interacting phenoxy pyridine and phenyl sulfanyl pyridine analogues for cancer therapy.

Anchoori RK, Kortenhorst MS, Hidalgo M, Sarkar T, Hallur G, Bai R, Diest PJ, Hamel E, Khan SR. Anchoori RK, et al. Among authors: khan sr. J Med Chem. 2008 Oct 9;51(19):5953-7. doi: 10.1021/jm800203e. Epub 2008 Sep 9. J Med Chem. 2008. PMID: 18778046 Free PMC article.

7

In vitro and in vivo clinical pharmacology of dimethyl benzoylphenylurea, a novel oral tubulin-interactive agent.

Rudek MA, Zhao M, Smith NF, Robey RW, He P, Hallur G, Khan S, Hidalgo M, Jimeno A, Colevas AD, Messersmith WA, Wolff AC, Baker SD. Rudek MA, et al. Clin Cancer Res. 2005 Dec 1;11(23):8503-11. doi: 10.1158/1078-0432.CCR-05-1037. Clin Cancer Res. 2005. PMID: 16322314 Clinical Trial.

8

A 5-fluorodeoxyuridine prodrug as targeted therapy for prostate cancer.

Mhaka A, Denmeade SR, Yao W, Isaacs JT, Khan SR. Mhaka A, et al. Among authors: khan sr. Bioorg Med Chem Lett. 2002 Sep 2;12(17):2459-61. doi: 10.1016/s0960-894x(02)00433-x. Bioorg Med Chem Lett. 2002. PMID: 12161157

9

Rational design of novel antiandrogens for neutralizing androgen receptor function in hormone refractory prostate cancer.

Singh P, Hallur G, Anchoori RK, Bakare O, Kageyama Y, Khan SR, Isaacs JT. Singh P, et al. Among authors: khan sr. Prostate. 2008 Oct 1;68(14):1570-81. doi: 10.1002/pros.20821. Prostate. 2008. PMID: 18668523 Free PMC article.

10

Modified synthesis and antiangiogenic activity of linomide.

Khan SR, Mhaka A, Pili R, Isaacs JT. Khan SR, et al. Bioorg Med Chem Lett. 2001 Feb 26;11(4):451-2. doi: 10.1016/s0960-894x(00)00699-5. Bioorg Med Chem Lett. 2001. PMID: 11229745

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

587 results

Search Page

Filters